CD8A and neoplasm: CD8+ T cells play a crucial role in antitumor immunity and the clinical success of immunotherapies (9, , –12), and MHC-I expression on tumor cells presenting antigens is crucial for CD8+ T cells to recognize the malignant cells (14, 15).